title: Results of an artificial-lung survey to lung transplant program directors.
abstract: BACKGROUND
  Lung transplantation is the only treatment for patients with end-stage lung disease. However, the scarcity of donor organs illustrates the need for alternatives. Recent success in the use of ventricular assistance has stimulated research in technology designed as a bridge to lung transplantation. Some laboratories have demonstrated significant advances in the development of artificial lungs, and clinical applications are on the horizon. In preparation, we sought to gather information from the lung transplant community regarding issues related to testing and potential trials of artificial lungs.
  
  
  METHODS
  We constructed a survey and distributed it to lung transplant program directors recognized by the United Network for Organ Sharing. Topics included required animal studies, preferred designs, logistics of clinical trials, and patient diagnoses most appropriate for such a trial.
  
  
  RESULTS
  The 31 programs responding to the survey performed 72% of all lung transplants in the United States in 1999. Ninety-seven percent supported a Phase I trial using an artificial lung as a bridge to lung transplantation. Additionally, 58% specifically supported a trial in which organ allocation would be prioritized to enrolled patients. Idiopathic pulmonary fibrosis was the diagnosis thought most appropriate for inclusion in initial clinical trials.
  
  
  CONCLUSIONS
  Widespread support exists for the development and use of an artificial lung as a bridge to lung transplantation. Information from transplant centers regarding device design and application can influence laboratories developing artificial lungs, and such communication will be essential as this technology progresses from the bench-top to the bedside.
authors.affiliation: Department of Surgery, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Haft
authors.forename: Bartley P
authors.initials: BP
authors.lastname: Griffith
authors.forename: Ronald B
authors.initials: RB
authors.lastname: Hirschl
authors.forename: Robert H
authors.initials: RH
authors.lastname: Bartlett
mesh_terms: D000818:Animals; D001187:Artificial Organs; D017321:Clinical Trials, Phase I as Topic; D019538:Health Care Surveys; D006801:Humans; D008168:Lung; D008171:Lung Diseases / Q000601:surgery; D016040:Lung Transplantation; D015397:Program Evaluation; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology